Your browser doesn't support javascript.
loading
Systemic antibiotics in the surgical treatment of peri-implantitis: A randomized placebo-controlled trial.
Riben Grundström, Caroline; Lund, Bodil; Kämpe, Johan; Belibasakis, Georgios N; Hultin, Margareta.
Afiliação
  • Riben Grundström C; Department of Periodontology, Specialist Clinic Kaniken, Public Dental Health Service, Uppsala, Sweden.
  • Lund B; Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Kämpe J; Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Belibasakis GN; Medical Unit of Plastic Surgery and Oral and Maxillofacial Surgery, Department for Oral and Maxillofacial Surgery and Jaw Orthopedics, Karolinska University Hospital, Stockholm, Sweden.
  • Hultin M; Department of Plastic and Oral and Maxillofacial Surgery, Uppsala University Hospital, Uppsala, Sweden.
J Clin Periodontol ; 51(8): 981-996, 2024 08.
Article em En | MEDLINE | ID: mdl-38699828
ABSTRACT

AIM:

To study the clinical, radiographic and microbiological outcomes after surgical treatment of peri-implantitis, with or without adjunctive systemic antibiotics. MATERIALS AND

METHODS:

Eighty-four patients (113 implants) with peri-implantitis were randomized into three groups (A, amoxicillin and metronidazole; B, phenoxymethylpenicillin and metronidazole; or C, placebo). Treatment included resective surgery and implant surface decontamination with adjunctive antibiotics or placebo. Primary outcomes were probing pocket depth (PPD) reduction and marginal bone level (MBL) stability. Secondary outcomes were treatment success (defined as PPD ≤ 5 mm, bleeding on probing [BOP] ≤ 1site, absence of suppuration on probing [SOP] and absence of progressive bone loss of >0.5 mm), changes in BOP/SOP, mucosal recession (REC), clinical attachment level (CAL), bacterial levels and adverse events. Outcomes were evaluated for up to 12 months. The impact of potential prognostic indicators on treatment success was evaluated using multilevel logistic regression analysis.

RESULTS:

A total of 76 patients (104 implants) completed the study. All groups showed clinical and radiological improvements over time. Statistically significant differences were observed between groups for MBL stability (A = 97%, B = 89%, C = 76%), treatment success (A = 68%, B = 66%, C = 28%) and bacterial levels of Aggregatibacter actinomycetemcomitans and Tannerella forsythia, favouring antibiotics compared to placebo. Multiple regression identified antibiotic use as potential prognostic indicator for treatment success. Gastrointestinal disorders were the most reported adverse events in the antibiotic groups.

CONCLUSIONS:

Adjunctive systemic antibiotics resulted in additional improvements in MBL stability. However, the potential clinical benefits of antibiotics need to be carefully balanced against the risk of adverse events and possible antibiotic resistance.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peri-Implantite / Amoxicilina / Metronidazol / Antibacterianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peri-Implantite / Amoxicilina / Metronidazol / Antibacterianos Idioma: En Ano de publicação: 2024 Tipo de documento: Article